Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Repeat use of human recombinant bone morphogenetic protein-2 for second level lumbar arthrodesis.
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Repeat use of human recombinant bone morphogenetic protein-2 for second level lumbar arthrodesis.
Repeat use of human recombinant bone morphogenetic protein-2 for second level lumbar arthrodesis. Spine (Phila Pa 1976). 2011 Feb 01; 36(3):192-6.
View in:
PubMed
subject areas
Animals
Arthrodesis
Bone Morphogenetic Protein 2
Cattle
Humans
Lumbar Vertebrae
Prospective Studies
Rabbits
Radiography
Recombinant Proteins
Retreatment
Spinal Fusion
Transforming Growth Factor beta
authors with profiles
Kern Singh